Antonella Berry-Brincat, Joyce Burns, Raghavan Sampath
Index: Ophthal. Plast. Reconstr. Surg. 29(5) , 400-2, (2013)
Full Text: HTML
To describe a simple technique to correct tarsal lower eyelid ectropion with or without marked eyelid laxity (The Leicester Modified Suture technique).A retrospective interventional case series of patients undergoing correction of tarsal ectropion with inverting sutures. The study adhered to the principles of the Declaration of Helsinki.Twenty patients (25 eyelids) met the inclusion criteria. The success of the procedure was assessed by improvement of symptoms, eyelid position, and the need for reoperation. The mean postoperative follow up was 3.6 months (range 2-15 months). Eighteen patients (90%) had a successful outcome, while in 2 patients (10%) the outcome was satisfactory, as there was mild residual eversion of the eyelids. None of the patients required reoperation.Tarsal lower eyelid ectropion can be surgically challenging to correct via the transconjunctival plication or subciliary reattachment of retractors. This method is simple to use, resulting in an excellent outcome with no tissue dissection. This technique is easy to learn and implement for oculoplastic surgeons at all levels of experience.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Poly(DL-Lactide-Co-Glycolide)
CAS:26780-50-7 |
C5H8O5 |
Simple measurements for prediction of drug release from poly...
2015-05-01 [Eur. J. Pharm. Biopharm. 92 , 1-7, (2015)] |
Induction of long-lasting protective immunity against Toxopl...
2013-01-01 [Parasit. Vectors 6 , 34, (2013)] |
Reduced postoperative chronic pain after tension-free inguin...
2014-01-01 [J. Am. Coll. Surg. 218(1) , 102-7, (2014)] |
Effect of water on exenatide acylation in poly(lactide-co-gl...
2013-09-15 [Int. J. Pharm. 454(1) , 344-53, (2013)] |
Local delivery of biodegradable pirfenidone nanoparticles am...
2012-12-21 [Nanotechnology 23(50) , 505101, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved